FDA inspection
Southern Research Institute: FDA inspection ending Feb 17, 2007
FDA inspection 461170 · No Action Indicated (NAI) · Birmingham, AL
Key facts
| Inspection ID | 461170 |
|---|---|
| Firm | Southern Research Institute |
| FEI number | 1045323 |
| Address | 2000 9th Ave S |
| City | Birmingham |
| State | AL |
| ZIP | 35205-2708 |
| Fiscal year | 2007 |
| Inspection end date | Feb 17, 2007 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Bio-Research Monit: Human Drugs|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products|Vaccines and Allergenic Products |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data